Evolus, Inc.
(NASDAQ : EOLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.83%36.020.8%$762.70m
JNJJohnson & Johnson
0.49%123.520.6%$757.81m
ABBVAbbVie, Inc.
-0.45%105.752.1%$746.25m
MRKMerck & Co., Inc.
1.50%59.330.6%$603.69m
BMYBristol-Myers Squibb Company
0.54%52.621.4%$457.39m
LLYEli Lilly and Company
0.75%82.841.0%$344.34m
AZNAstraZeneca PLC Sponsored ADR
-0.61%36.831.3%$160.85m
NVSNovartis AG Sponsored ADR
-0.51%76.450.2%$109.82m
GSKGlaxoSmithKline plc Sponsored ADR
-0.32%40.200.2%$109.43m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.77%48.250.1%$74.47m
SNYSanofi Sponsored ADR
-1.04%38.530.2%$42.92m
LCILannett Company, Inc.
0.90%16.9037.9%$13.57m
EPIXESSA Pharma Inc
1.83%3.340.0%$0.17m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.57%1.881.7%$0.12m

Company Profile

Evolus, Inc. is a medical aesthetics company. The company is engaged in providing physicians and patients with expanded choices in aesthetic procedures and treatments. Evolus was founded in November, 2012 and is headquartered in Irvine, CA.